PharmaSGP Holding SE/€PSG
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About PharmaSGP Holding SE
PharmaSGP Holding SE is a European pharmaceutical company specializing in the development and sale of non-prescription consumer health products. The company's portfolio includes herbal medicines and health supplements designed for various therapeutic areas, including pain relief, sexual wellbeing, and skin health. Founded in 2008, PharmaSGP has focused on leveraging plant-based active ingredients to provide alternative treatment options. The company is headquartered in Gräfelfing, Germany, and operates primarily within the European market. PharmaSGP's strategic approach is underscored by its emphasis on innovation and its commitment to expanding an evidence-based product lineup.
Ticker
€PSG
Sector
Primary listing
XETRA
Employees
91
Headquarters
Website
PSG Metrics
BasicAdvanced
€345M
17.25
€1.68
-0.04
€0.05
0.17%
Price and volume
Market cap
€345M
Beta
-0.04
52-week high
€29.95
52-week low
€18.97
Average daily volume
3.9K
Dividend rate
€0.05
Financial strength
Current ratio
2.68
Quick ratio
2.089
Long term debt to equity
158.408
Total debt to equity
180.879
Dividend payout ratio (TTM)
82.75%
Interest coverage (TTM)
6.46%
Profitability
EBITDA (TTM)
36.904
Gross margin (TTM)
90.55%
Net profit margin (TTM)
16.14%
Operating margin (TTM)
23.06%
Effective tax rate (TTM)
25.06%
Revenue per employee (TTM)
€1,340,000
Management effectiveness
Return on assets (TTM)
13.58%
Return on equity (TTM)
48.46%
Valuation
Price to earnings (TTM)
17.245
Price to revenue (TTM)
2.783
Price to book
9.42
Price to tangible book (TTM)
-17.11
Price to free cash flow (TTM)
16.458
Free cash flow yield (TTM)
6.08%
Free cash flow per share (TTM)
1.756
Dividend yield (TTM)
0.17%
Forward dividend yield
0.17%
Growth
Revenue change (TTM)
13.80%
Earnings per share change (TTM)
11.30%
3-year revenue growth (CAGR)
18.40%
3-year earnings per share growth (CAGR)
21.76%
3-year dividend per share growth (CAGR)
4.26%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for PharmaSGP Holding SE stock?
PharmaSGP Holding SE (PSG) has a market cap of €345M as of August 23, 2025.
What is the P/E ratio for PharmaSGP Holding SE stock?
The price to earnings (P/E) ratio for PharmaSGP Holding SE (PSG) stock is 17.25 as of August 23, 2025.
Does PharmaSGP Holding SE stock pay dividends?
Yes, the PharmaSGP Holding SE (PSG) stock pays dividends to shareholders. As of August 23, 2025, the dividend rate is €0.05 and the yield is 0.17%. PharmaSGP Holding SE has a payout ratio of 82.75% on a trailing twelve-month basis.
When is the next PharmaSGP Holding SE dividend payment date?
The next PharmaSGP Holding SE (PSG) dividend payment date is unconfirmed.
What is the beta indicator for PharmaSGP Holding SE?
PharmaSGP Holding SE (PSG) has a beta rating of -0.04. This means that it has an inverse relation to market volatility.